Subscribe to RSS
Pharmacokinetics and metabolism of Dihydroquercetin isolated from Larix sibirica Ledeb
The aim of this study was the investigation of the pharmacokinetic processes of Dihydroquercetin isolated from Larix sibirica Ledeb (DHQ; CAS N° 480–18–2, C15H12O7; 2,3-dihydro-2-(3,4-dihydroxyphenil)-3,5,7-trihydroxyphenil-4H-1-benzopyran-4-on; 3,5,7,3',4'-penta-hydroxyflavon) and identification it metabolites in blood plasma and urine after single intravenous, oral administration (12.5, 50mg/kg) in rats. Blood plasma and urine samples of rats, containing DHQ-glucuronide were underwent enzymatic hydrolysis with purified β-glucuronidase solution (1). Hydrolyzed samples were extracted with diethyl ether from acidic medium. Quantification of DHQ was performed by reverse-phase HPLC with UV- and MS-detection. It was established that DHQ is a short-living drug (the half-elimination time was not exceed of 1.25h). The drug was determined for 6h in rats. Absolute bioavailability is about 24%. 8.30% of DHQ from administered oral dose (250mg/kg) was excreted with daily urine. Analyzed compound was not detected in feces. In daily urine were detected and preliminary identified in addition to unchanged substance 7 products its biotransformation: stereoisomer of DHQ, methylated metabolite of DHQ, stereoisomer of methylated metabolite of DHQ, DHQ-glucuronide, stereoisomer of DHQ-glucuronide, methylated metabolite of DHQ-glucuronide and stereoisomer of methylated metabolite of DHQ-glucuronide.
References: Schulz, H.U. et al. (2005) Arzneim.-Forsh./Drug Res. 55:15–22